Shareholders' Equity (Details) - USD ($)				5 Months Ended	12 Months Ended
Shareholders' Equity (Details) - USD ($)	Dec. 31, 2024	Jul. 23, 2024	Feb. 09, 2024	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024	Apr. 08, 2025	Nov. 11, 2024	Mar. 31, 2024
Shareholders’ Equity [Line Items]
Common Shares Outstanding, Percentage		40.00%
Remaining stock option			80,000
Vested term			2 years
Aggregate grant fair value (in Dollars)						$ 424
Chief Executive Officer [Member]
Shareholders’ Equity [Line Items]
Number of stock options			3,800,000
Stock options exercise price per share. (in Dollars per share)			$ 0.001
Options vested			1,900,000						237,500
Remaining stock option			1,900,000
Exercisable term			8 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)			$ 4,770,000
Board of Directors Chairman [Member]
Shareholders’ Equity [Line Items]
Number of stock options			160,000
Stock options exercise price per share. (in Dollars per share)			$ 0.4
Options vested			80,000						10,000
Vested term			2 years
Exercisable term			8 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)			$ 190,000
Successor [Member]
Shareholders’ Equity [Line Items]
Options vested	4,960,000			4,960,000	4,270,000	4,960,000
Vested term				6 years 1 month 6 days	4 years 10 months 24 days
Exercisable term	6 years 1 month 6 days	6 years 1 month 6 days		6 years 1 month 6 days	4 years 10 months 24 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)
Options exercised				2,800,000
Plan Amendment [Member]
Shareholders’ Equity [Line Items]
Number of shares issued			20,000,000
Global Share Incentive Plan Two Thousand and Twenty-One [Member]
Shareholders’ Equity [Line Items]
Number of stock options	740,000			740,000		740,000
Stock options exercise price per share. (in Dollars per share)	$ 0.3			$ 0.3		$ 0.3
Options vested	560,000			560,000		560,000
Remaining stock option	180,000			180,000		180,000
Exercisable term						10 years
Remaining non-controlling interest (in Dollars)							$ 809,000
Ordinary Shares [Member]
Shareholders’ Equity [Line Items]
Number of shares issued		23,171,642
Ordinary Shares [Member] \| Chief Operating Officer [Member]
Shareholders’ Equity [Line Items]
Stock options exercise price per share. (in Dollars per share)	$ 0.001			$ 0.001		$ 0.001
Ordinary Shares [Member] \| Successor [Member]
Shareholders’ Equity [Line Items]
Options exercised				2,800,000
Share-Based Payment Arrangement, Option [Member] \| Ordinary Shares [Member] \| Successor [Member] \| President [Member]
Shareholders’ Equity [Line Items]
Options exercised	2,800,000
Share-Based Payment Arrangement, Option [Member] \| Ordinary Shares [Member] \| Successor [Member] \| Chief Operating Officer [Member]
Shareholders’ Equity [Line Items]
Options exercised	2,800,000
Maximum [Member]
Shareholders’ Equity [Line Items]
Number of shares reserved for issuance								20,000,000
Minimum [Member]
Shareholders’ Equity [Line Items]
Number of shares reserved for issuance								10,000,000

Revium Rx. 10-K